Search result for 'non-core assets'

IHCL is eyeing strategic acquisitions to expand its presence in key markets and enter new destinations in Europe and Southeast Asia.

Reliance Infrastructure to monetise Pune-Satara Toll Road. Cube Highways to acquire 100% stake. Debt reduction & growth initiatives planned.

Adani Ports & SEZ Ltd. announces a USD 2.4 billion non-cash acquisition of a coal export terminal in Australia, strengthening its presence in the Asia-Pacific region.

Akzo Nobel India will sell its powder coatings business and international research and development center to its Dutch parent firm Akzo Nobel NV in a Rs 2,143-crore deal. The transaction is...

Shriram Properties has sold a 3.9 acre land parcel in Chennai to a healthcare and education group. This sale is part of the company's strategy to monetize non-core assets and focus on residential...

Patel Engineering has sold its remaining 9.99% stake in Welspun Michigan Engineers Ltd for Rs 100 crore, as part of its strategy to monetize non-core assets. The divestment will contribute to the...

Suzlon Group has monetized non-core assets worth Rs 440 crore, including its corporate headquarters, as part of its strategy to become asset-light and fund growth.

India Cements Ltd. reported a consolidated net loss of Rs 6.58 crore for the third quarter ended December 2023, citing stressed working capital conditions and lower capacity utilization.

Piramal Enterprises Ltd. posted a Rs 2,378 crore loss in Q3 due to provisions related to RBI norms on alternative investment funds. Learn more about the impact on the NBFC.

Experts urge government to expedite CPSE privatization by promoting land record digitization and empowering NLMC to interact with state revenue departments for updating records.

India's disinvestment target for FY24 is likely to be missed again as the government prioritizes minority stake sales over outright privatization ahead of general elections.

Tata Power plans to invest Rs 60,000 crore over the next three years, with a focus on renewable energy. The company aims to double revenues and profits in the next four years.

Biocon Biologics has sold its dermatology and nephrology branded formulations business units in India to Eris Lifesciences for Rs 366 crore. The deal is expected to close by the end of November 2023.

India Cements reported a narrowed Q2 loss of Rs 85.54 crore, with revenue dipping 4.7% to Rs 1,264.39 crore. The company attributes the loss to reduced selling prices and volume. Read more.

India Cements Ltd reports a standalone net loss of Rs 81.39 crore for Q2 FY24, down from Rs 137.58 crore in the same period last year. Read more.